Malignant fibrous histiocytoma: Changing perceptions and management challenges

Journal of the American Academy of Dermatology

Volumn 67, Issue 6, 2012, Pages 1335-1341

  Henderson, Michael T ^a   Hollmig, S Tyler ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AFX; atypical fibroxanthoma; IHC; immunohistochemistry; malignant fibrous histiocytoma; MFH; MMS; Mohs micrographic surgery; radiation therapy; RT; undifferentiated pleomorphic sarcoma; UPS

Indexed keywords

IPILIMUMAB; SUNITINIB;

CANCER PROGNOSIS; CANCER RADIOTHERAPY; CLINICAL DECISION MAKING; CLINICAL FEATURE; CONTROLLED STUDY; HEREDITY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALIGNANT FIBROUS HISTIOCYTOMA; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; SKIN NEOPLASMS;

EID: 84869116914     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.04.013     Document Type: Review

References (64)

1. G.C. Ang, R.K. Roenigk, C.C. Otley, K.P. Phillips, and A.L. Weaver More than 2 decades of treating atypical fibroxanthoma at Mayo Clinic: what have we learned from 91 patients? Dermatol Surg 35 2009 765 772
2. S.S. Banerjee, and M. Harris Morphological and immunophenotypic variations in malignant melanoma Histopathology 36 2000 387 402
3. A. Dettrick, and G. Strutton Atypical fibroxanthoma with perineural or intraneural invasion: report of two cases J Cutan Pathol 33 2006 318 322
4. H. Ly, D. Selva, C.L. James, and S.C. Huilgol Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma Australas J Dermatol 45 2004 106 109
5. S. Marcet Atypical fibroxanthoma/malignant fibrous histiocytoma Dermatol Ther 21 2008 424 427
6. J. Nishio, H. Iwasaki, K. Nabeshima, M. Ishiguro, T. Isayama, and M. Naito Establishment of a new human pleomorphic malignant fibrous histiocytoma cell line, FU-MFH-2: molecular cytogenetic characterization by multicolor fluorescence in situ hybridization and comparative genomic hybridization J Exp Clin Rese 29 2010 153
7. S.L. Kauffman, and A.P. Stout Histiocytic tumors (fibrous xanthoma and histiocytoma) in children Cancer 14 1961 469 482
8. P.R. Ros, M. Viamonte, and A.M. Rywlin Malignat fibrous histiocytoma: Mesenchymal tumor of ubiquitous origin AJR 142 1984 753 759
9. C.D. Fletcher Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on159 tumors diagnosed as pleomorphic sarcoma Am J Surg Pathol 16 1992 213 228
10. J.R. Toro, L.B. Travis, H.J. Wu, C.D. Fletcher, and S.S. Devesa Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases Int J Cancer 119 2006 2922 2930
11. D.W. Clark, B.A. Moore, S.R. Patel, B.A. Guadagnolo, D.B. Roberts, and E.M. Sturgis Malignant fibrous histiocytoma of the head and neck region Head & Neck 33 2011 303 308
12. C. Gazziola, N. Cordani, and B. Wasserman Malignant fibrous histiocytoma: a proposed cellular origin and identification of its characterizing gene transcripts Int J Oncol 23 2003 343 351
13. F.M. Enzinger, and S.W. Weiss Malignant fibrohistiocytic tumors Soft tissue tumors 3rd ed 2001 Mosby St. Louis 252 273
14. A. Franchi, and M. Santucci Tenascin expression in cutaneous fibrohistiocytic tumors. Immunohistochemical investigation of 24 cases Am J Dermatopathol 18 1996 454 459
15. INK4A) and other genomic imbalances in human malignant fibrous histiocytoma Cancer Genet Cytogenet 118 2000 89 98
16. F.J. Stadler, A.S. Scott, and D.B. Brown Malignant fibrous tumours Semin Cutan Med Surg 17 2 1998 141 152
17. A. Sakamoto, Y. Oda, E. Itakura, Y. Oshiro, O. Nikaido, and Y. Iwamoto Immunosuppression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma Mod Pathol 14 2001 581 588
18. E.M. Sturgis, and B.O. Potter Sarcomas of the head and neck region Curr Opin Oncol 15 2003 239 252
19. R. Luzzatto, S. Grossmann, J.G. Scholl, and M. Recktenvaid Postradiation pleomorphic malignant fibrous histiocytoma of the breast Acta Cytol 30 1986 48 50
20. T. Inoshita, and G.A. Youngberg Malignant fibrous histiocytoma arising in previous surgical sites. Report of two cases Cancer 53 1984 176 183
21. J.Y. Ko, C.L. Chen, L.T. Lui, and M.M. Hsu Radiation-induced malignant fibrous histiocytoma in patients with nasopharyngeal carcinoma Arch Otolaryngol Head Neck Surg 122 1996 535 538
22. T. Satomi, M. Watanabe, T. Kaneko, J. Matsubayashi, T. Nagao, and H. Chiba Radiation-induced malignant fibrous histiocytoma of the maxilla Odontology 99 2011 203 208 Epub 2011 Apr 13
23. C.P. Wang, Y.L. Chang, L.L. Ting, T.L. Yang, J.Y. Ko, and P.J. Lou Malignant fibrous histiocytoma of the sinonasal tract Head Neck 31 2009 85 93
24. A.H. Reid, M.M. Tsai, D.J. Venzon, C.F. Wright, E.E. Lack, and T.J. O'Leary MDM2 amplification, P53 mutation, and accumulation of the P53 gene product in malignant fibrous histiocytoma Diagn Mol Pathol 5 1996 65 73
25. W.H. Weng, J. Ahlen, W.O. Lui, O. Brosjo, S.T. Pang, and A. von Rosen Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis Br J Cancer 89 2000 720 726
26. A. Sakamoto, Y. Oda, E. Itakura, Y. Ohsiro, S. Tamiya, and Y. Honda H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma Hum Pathol 32 2001 1225 1231
27. NCCN. NCCN Clinical Practice Guidelines in Oncology: Soft Tissue Sarcoma V.2.2007. Available online at http://www.globalgist.org/docs/NCCN-guidelines. pdf. Accessed January 23, 2012.
28. Von Mehren M, Benjamin RS, Bui MM, Casper ES, Conrad EU, DeLaney TF, et al. NCCN Clinical Practice Guidelines in Oncology: Soft Tissue Sarcoma, version 2.2011. Available at: http://www.nccn.org/professionals/physician-gls/pdf/ sarcoma.pdf. Accessed January 23, 2012.
29. M.M. Kearney, E.H. Soule, and J.C. Ivins Malignant fibrous histiocytoma: a retrospective study of 167 cases Cancer 45 1980 167 178
30. Y.S. Lau, A. Sabokbar, C.L.M.H. Gibbons, H. Giele, and N. Athanasou Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue Hum Pathol 36 2005 945 954
31. th Annual Seminar of San Antonio Society of Pathologists, 1961 Tex State J Med 59 1963 664 667
32. L.J. Iorizzo, and M.D. Brown Atypical fibroxanthoma: a review of the literature Dermatol Surg 37 2011 146 157
33. R.A. Mathew, S.M. Schlauder, K.B. Calder, and M.B. Morgan CD117 immunoreactivity in atypical fibroxanthoma Am J Dermatopathol 30 2008 34 36
34. T.W. Beer, and D. Haig CD117 is not a useful marker for diagnosing atypical fibroxanthoma Am J Dermatopathol 31 2009 649 652
35. A.L. Folpe, and K. Cooper Best practices in diagnostic immunohistochemistry: pleomorphic cutaneous spindle cell tumors Arch Pathol Lab Med 131 2007 1517 1524
36. J.E. Dotto, and E.J. Glusac P63 is a useful marker for cutaneous spindle cell squamous cell carcinoma J Cutan Pathol 33 2006 413 417
37. T. Mentzel, A. Beham, D. Katenkamp, A.P. Die Tos, and C.D. Fletcher Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance Am J Surg Pathol 22 1998 576 587
38. H. Kutzner Expression of the human progenitor cell antigen (CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue J Am Acad Dermatol 28 1993 613 617
39. C.L. Haycox, P.B. Odland, S.M. Olbricht, and M. Piepkorn Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment J Am Acad Dermatol 37 1997 438 444
40. R. Lazova, R. Moynes, D. May, and G. Scott LN-2 (CD74): a market to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma Cancer 79 1997 2115 2124
41. S. de Feraudy, N. Mar, and R.H. McCalmont Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma Am J Surg Pathol 32 2008 1111 1122
42. P.H. Hartel, J. Jackson, B.S. Ducatman, and P. Zhang CD99 immunoreactivity in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma: a useful diagnostic marker J Cutan Pathol Suppl 2 33 2006 24 28
43. S. Kalayanarooj Benign and malignant soft tissue mass: magnetic resonance imaging criteria for discrimination J Med Assoc Thai 91 2008 74 81
44. S.W. Weiss, and F.M. Enzinger Malignant fibrous histiocytoma: an analysis of 200 cases Cancer 41 1978 2250 2266
45. D.N. Weingrad, and S.A. Rosenberg Early lymphatic spread of osteogenic and soft-tissue sarcomas Surgery 84 1978 231 240
46. Y. Fong, D.G. Coit, J.M. Woodruff, and M.F. Brennan Lymph node metastasis from soft tissue sarcoma in adults: analysis of data from a prospective database of 1772 sarcoma patients Ann Surg 217 1993 72 77
47. H. Schöder, S.M. Larson, and H.W. Yeung PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies J Nucl Med 45 1 Suppl 2004 72S 81S
48. M. Peiper, D. Zurakowski, W.T. Knoefel, and J.R. Izbicki Malignant fibrous histiocytoma of the extremities and trunk: an institutional review Surgery 135 2004 59 66
49. S.W. Weiss, and F.M. Enzinger Myxoid variant of malignant fibrous histiocytoma Cancer 39 1977 1672 1685
50. A.F. Nascimento, and P.R. Chandrajit Diagnosis and management of pleomorphic sarcomas (so-called "MFH") in adults J Surg Oncol 97 2008 330 339
51. M.J. Huether, J.A. Zitelli, and D.G. Brodland Mohs micrographic surgery for the treatment of spindle cell tumors of the skin J Am Acad Dermatol 44 2001 656 659
52. M.D. Brown, and N.A. Swanson Treatment of malignant fibrous histiocytoma and atypical fibroxanthomas with micrographic surgery J Dermatol Surg Oncol 15 1989 1287 1292
53. W.J. Pao, and M.V. Pilepich Postoperative radiotherapy in the treatment of extremity soft tissue sarcomas Int J Radiat Oncol Biol Phys 19 1990 907 911
54. D. Nori, K. Schupak, M.H. Shiu, and M.F. Brennan Role of brachytherapy in recurrent extremity sarcoma in patients treated with prior surgery and irradiation Int J Radiat Oncol Biol Phys 20 1991 1229 1233
55. H.D. Suit, W.O. Russell, and R.G. Martin Management of patients with sarcoma of soft tissue in an extremity Cancer 31 1973 1247 1255
56. H.D. Suit, and I. Spiro Role of radiation in the management of adult patients with sarcoma of soft tissue Semin Surg Oncol 10 1994 347 356
57. A.J. Mundt, A. Awan, G.S. Sibley, M. Simon, S.J. Rubin, and B. Samuels Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: clinical and radiobiological results Int J Radiat Oncol Biol Phys 32 1995 977 985
58. J. Issakov, Y. Kollender, V. Soyfer, J. Bickels, G. Flusser, and I. Meller A single-team experience of limb sparing approach in adults with high-grade malignant fibrous histiocytoma Oncol Rep 14 2005 1071 1076
59. B. O'Sullivan, A.M. Davis, R. Turcotte, R. Bell, C. Catton, and P. Chabot Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial Lancet 359 2002 2235 2241
60. R. Marchese, P. Bufo, G. Carrieri, and G. Bove Malignant fibrous histiocytoma of the kidney treated with nephrectomy and adjuvant radiotherapy: a case report Case Report Med 2010 2010 4
61. M. Tarján, G. Cserni, and Z. Szabó Malignant fibrous histiocytoma of the kidney Scand J Urol Nephrol 35 2001 518 520
62. Clinical Trial Registry. Available online at: http://clinicaltrials.gov/ ct2/show/NCT00556881?term=ipilimumab+malignant+fibrous&rank=1. Accessed November 22, 2011.
63. Clinical Trial Registry. Available online at: http://clinicaltrials.gov/ ct2/show/NCT00400569?term=sunitinib+malignant+fibrous&rank=2. Accessed December 29, 2011.
64. T. Sabesan, W. Xuexi, Q. Yongfa, T. Pingzhang, and V. Ilankovan Malignant fibrous histiocytoma: outcome of tumors in the head and neck compared with those in the trunk and extremities Br J Oral Maxillofac Surg 44 2006 209 212